1Professor of Neonatology, Mashhad University of Medical Sciences, Mashhad, Iran
2Neonatologist, Mashhad University of Medical Sciences, Mashhad, Iran
3Associate Professor of Neonatology, Mashhad University of Medical Sciences, Mashhad, Iran
Background: In the recent decades, the prevalence of nosocomial infections in neonates has grown and almost 21% of preterm neonates experience these kinds of infections. Some factors were proposed to have a protective effect against neonatal infections through promoting the development of the immune system of the newborn. This study aimed to evaluate the efficacy of oral glutamine supplementation in management of neonatal sepsis. Methods: Neonates were randomly allocated to case and control groups. The infants in the case group received 0.3 g/kg/day glutamine, every eight hours from three days of age to 28 days. Hospital stay duration and occurrence of necrotizing enterocolitis (NEC) as well as sepsis were recorded for each patient. Data were analyzed using SPSS version 16. Results: In general, 105 neonates were enrolled in the study, 52 of who were allocated to the glutamine group and 53 neonates assigned to the control group. The results showed that 52 (49.5%) cases were male and 53 (50.6%) were female with mean gestational age of 30±2 weeks. Life threatening infections occurred more commonly in the control group (P=0.036). Six neonates (11.5 %) in the glutamine group and eight (15.1 %) in the control group developed clinical sepsis (P=0.592). NEC occurred only in the control group (P=0.118). Mean durations of hospital stay in the glutamine and placebo groups were 20±12 days and 26±18 days (P=0.065), respectively. Mean durations of oxygen therapy were 6±5 days and 16±11 days for the glutamine and control groups, respectively (P=0.039). Conclusion: Oral glutamine administration reduced life threatening infections and duration of receiving supplemental oxygen.
Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis. 2006; 19(3):290–7.
Pietzak M. Bacterial colonization of the neonatal gut. J Pediatr Gastroenterol Nutr. 2004; 38(4):389–91.
Borghesi A, Tzialla C, Decembrino L, Manzoni P, Stronati M. New possibilities of prevention of infection in the newborn. J Matern Fetal Neonatal Med. 2011; 24(Suppl 2):28–30.
10. Blakey JL, Lubitz L, Barnes GL, Bishop RF, Campbell NT, Gillam GL. Development of gut colonization in pre-term neonates. J Med Microbiol. 1982; 15(14):519-29.
11. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition. 1999; 15(2):108-15.
12. Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition. 2002; 18(7-8):546-52.
13. Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001; 29(11):2075-80.
14. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med. 2002; 30(9):2022-9.
15. Neu J, DeMarco V, Li N. Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care. 2002; 5(1):69-75.
16. Poindexter BB, Ehrenkranz RA, Stoll B, Wright LL, Poole WK, Oh W, et al. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics. 2004; 113(5):1209-15.
17. Dammann O, Kuban KC, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev. 2002; 8(1):46-50.
18. Chen CM, Cheng KC, Li CF, Zhang H. The protective effects of glutamine in a rat model of ventilator-induced lung injury. J Thorac Dis. 2014; 6(12):1704-13.
19. Wagner JV, Moe-Byrne T, Grover Z, McGuire W. Glutamine supplementation for young infants with severe gastrointestinal disease. Cochrane Database Syst Rev. 2012; 7:CD005947.
20. Li ZH, Wang DH, Dong M. Effect of parenteral glutamine supplementation in premature infants. Chin Med J. 2007; 120(2):140-4.
21. Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, et al. Randomized trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet. 1998; 352(9130):772-6.
22. Vaughn P, Thomas P, Clark R, Neu J. Enteral glutamine supplementation and morbidity in low birth weight infants. J Pediatr. 2003; 142(6):662-8.
23. Bober-Olesińska K, Kornacka MK. Effects of glutamine supplemented parenteral nutrition on the incidence of necrotizing enterocolitis, nosocomial sepsis and length of hospital stay in very low birth weight infants. Med Wieku Rozwoj. 2005; 9(3 Pt 1):325-33.
24. Neu J, Roig JC, Meetze WH, Veerman M, Carter C, Millsaps M, et al. Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatr. 1997; 131(5):691-9.
26. Mohamad Ikram I, Quah BS, Noraida R, Djokomuljanto S, Faris Irfan CY, Van Rostenberghe H. A randomised controlled trial of glutamine-enriched neonatal parenteral nutrition in Malaysia. Singapore Med J. 2011; 52(5):356-60.
Martin RJ, Fanaroff AA, Walsh MC. Neonatal-perinatal medicine: diseases of the fetus and infant. 9th ed. Philadelphia: McGraw-Hill; 2008.